The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
Low and no-calorie sweeteners (LNCSs) help reduce sugar intake, but their long-term effects on metabolism, gut health, and ...
Until Insulet's Omnipod came on the market at the end of 2005, all insulin pumps consisted of a controller and insulin reservoir attached to the injection site by a long flexible tube. The Omnipod ...
Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes.
Two years ago, my 5-year-old grandson was rushed to the hospital, seriously ill. The diagnosis was Type 1 diabetes. For those ...
Magnesium supports many important functions in the body, including energy creation, blood sugar control, muscle and nerve ...
2d
Hosted on MSNFDA clears Tandem’s Control-IQ+ technology for type 2 diabetesThe US Food and Drug Administration (FDA) has cleared Tandem Diabetes Care’s Control-IQ+ technology, an automated insulin ...
2d
Daily Post Nigeria on MSNDeath threats hovering around me – NAFDAC boss, AdeyeyeThe Director-General of the National Agency for Food and Drug Administration and Control, NAFDAC, Prof Mojisola Adeyeye, has ...
The US FDA has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes.
Tandem Diabetes Care, Inc.’s Control-IQ+ Technology, used with the t:slim and Mobi insulin pumps, becomes the second AID ...
Fasting for 24 hours increases human growth hormone (HGH) levels independently of weight loss, with individuals with lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results